News on Sutenthttp://liverdiseaseinfo.com/topic/sutent2010-10-27T06:53:34ZHow Concerned Should Onyx Investors Be?2010-10-27T06:33:29ZSeekingAlphatag:liverdiseaseinfo.com,2010-10-27:/liver-diseases/concerned-onyx-investors-3372577a/...Pfizer Ends Trial of Sutent in Liver Cancer2010-10-27T06:53:34ZDrugs.comtag:liverdiseaseinfo.com,2010-10-27:/liver-diseases/pfizer-ends-trial-sutent-liver-cancer-3386542a/...Pfizer Discontinues Phase 3 Trial of Sutent in Advanced Hepatocellular Carcinoma2010-10-27T06:53:34ZDrugs.comtag:liverdiseaseinfo.com,2010-10-27:/liver-diseases/pfizer-discontinues-phase-3-trial-sutent-advanced-hepatocellular-carcinoma-3386543a/...Pfizer ends trial of Sutent in liver cancer2010-09-22T13:39:09ZAP Newstag:liverdiseaseinfo.com,2010-09-22:/liver-diseases/pfizer-ends-trial-sutent-liver-cancer-912894a/<div id="subtitle"><a title="Pfizer Inc." href="/topic/Pfizer+Inc." >Pfizer</a> says <a title="Sutent" href="/topic/Sutent" >Sutent</a> was not working better than Bayer's <a title="Nexavar" href="/topic/Nexavar" >Nexavar</a> as a treatment for liver cancer</div><div><p>Pfizer Inc. said Thursday it stopped a late-stage clinical study of its drug Sutent as a treatment for liver cancer.</p><p>Pfizer said patients who were treated with Sutent were not surviving as long as patients who were treated ...